474 Results (Page 19 of 19)
Egypt Markets Research Reports
Egypt Bariatric Surgery Devices Market Analysis
The Egypt Bariatric Surgery Devices Market was valued at $7.5 Mn in 2023 and is projected to grow at a CAGR of 6.7% from 2023 to 2023, to $11.7 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Baxter, Cook Medical, Medtronic, Johnson & Johnson among others.
Egypt CT Scan Market Analysis
Egypt CT Scan Market was valued at $12.91 Mn in 2023 and is predicted to grow at a CAGR of 9.37% from 2023 to 2030, to $24.16 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, increasing healthcare expenditure, an aging population, and technological advancements. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
Egypt Constipation Therapeutics Market Analysis
Egypt Constipation Therapeutics Market was valued at $51 Mn in 2022 and is estimated to reach $94 Mn in 2030, exhibiting a CAGR of 8% during the forecast period. The global growth of the constipation therapeutics market is driven by factors such as aging, sedentary lifestyles, and unhealthy dietary habits. The increasing elderly population, susceptible to chronic conditions, notably contributes to this expansion. Major players in this sector comprise Abbott, Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, GlaxoSmithKline, Merck & Co., Novartis, and Pfizer.
Egypt Bio-Implant Market Analysis
The Egypt Bio-implant Market was valued at $182 Mn in 2023 and is predicted to grow at a CAGR of 7.4/% from 2023 to 2030, to $300 Mn by 2030. The Egypt Bio-implant Market is growing due to like Increasing Chronic Disease Prevalence, Rising Disposable Income and Healthcare Spending, and Technological Innovations in Implant Materials. The market is primarily dominated by players such as Alexandria Advanced Technologies, Medica Egypt, Misr Medicare, Zimmer Biomet, Boston Scientific Corporation, Otto Bock Holding GmbH & Co. KG, and Medtronic plc.
Egypt Mental Health Apps Market Analysis
The Egypt Mental Health Apps Market was valued at $17.36 Mn in 2023 and is predicted to grow at a CAGR of 16.7% from 2023 to 2030, to $51.17 Mn by 2030. The key drivers of this industry include government support, rising awareness, and increasing demand. The industry is primarily dominated by players such as Calm, Happify, Headspace, and Safe Space among others.
Egypt Adult Malignant Glioma Therapeutics Market Analysis
The Egypt Adult Glioma Therapeutics Market is valued at around $6 Mn in 2022 and is projected to reach $14 Mn by 2030, exhibiting a CAGR of 10.4% during the forecast period. The Egypt Adult Malignant Glioma Market is driven by factors such as increased advancements in targeted therapies, increased insurance coverage and government support and most importantly, reliance on imported drugs causing low local competitiveness and higher opportunities of growth for newer market players. Key players in the Egypt Adult Malignant Glioma Therapeutics Market include companies like Roche, Novartis, Merck & Co., Pfizer, Bristol-Myers Squibb, AbbVie, Pharco, Eva Pharma, Siemens, etc. among others
Egypt Herbal Supplements Market Report
The Egypt Herbal Supplements Market was valued at $14.73 Mn in 2023 and is predicted to grow at a CAGR of 7.7% from 2023 to 2030, to $24.75 Mn by 2030. The key drivers of this industry include rising obesity rates, growing health awareness, and distribution channels. The industry is primarily dominated by players such as Himalaya Wellness, NOW Foods, Botanic Supplements, and Dabur among others.
Egypt Blood Disorder Therapeutics Market
Egypt Blood Disorder Therapeutics Market valued at $38 Mn in 2022, projected to reach $75 Mn by 2030 with a 9% CAGR. The market is fuelled due to a push from a mix of certain factors like the increased prevalence of Blood Disorders in the country, supported by increased awareness and acceptance and availability of treatment options due to recent technological advancements. The Egypt Blood Disorder Therapeutics Market encompasses various players across different segments, including Takeda, Roche, Novartis, Pfizer, AstraZeneca, Sanofi, Grifols, Octapharma, Pharco Pharmaceuticals, EVA Pharmaceuticals etc, among various others.
Egypt Clinical Nutrition for Chronic Kidney Diseases Market Analysis
Egypt Clinical Nutrition for Chronic Kidney Diseases Market was valued at $4.40 Mn in 2023 and is predicted to grow at a CAGR of 7.53% from 2023 to 2030, to $7.30 Mn by 2030. The key drivers of this industry include rising CKD prevalence, a growing geriatric population, and technological advancements. The industry is primarily dominated by Abbott Nutrition, Pfizer Inc., Bayer AG, and Nestlé Health Science among others.
Egypt Dental Endodontics Market Analysis
Egypt Dental Endodontics Market was valued at $4.90 Mn in 2023 and is predicted to grow at a CAGR of 5.8% from 2023 to 2030, to $7.30 Mn by 2030. The key drivers of this industry include increasing awareness of oral health, the rising prevalence of dental problems, and growing dental infrastructure. The industry is primarily dominated by Coltene, Dentsply Sirona, FKG Dentaire, and Ultradent Products among others.
Egypt Clinical Nutrition Market Analysis
The Egypt Clinical Nutrition Market was valued at $85.9 Mn in 2023 and is projected to grow at a CAGR of 6.84% from 2023 to 2023, to $136.5 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Bio Pharma, Eva Pharma, Bio Pure, SEDICO, Abbott Nutrition, Mead Johnson & Company, LLC among others
Egypt Breast Pump Market Report
The Egypt Breast Pump Market was valued at $8.2 Mn in 2023 and is predicted to grow at a CAGR of 10.1% from 2023 to 2030, to $16.1 Mn by 2030. The key drivers of the market include improving healthcare infrastructure, growing consumer awareness, and rising disposable incomes. The prominent players in the Egypt Breast Pump Market are Bistos, Ameda, Avent, Evenflo, and Pigeon, among others.
Egypt Cancer Induced Bone Diseases Therapeutics Market
Egypt Cancer Induced Bone Disease Therapeutics Market valued at $4 Mn in 2022, projected to reach $6 Mn by 2030 with a 7.3% CAGR. The key drivers of this industry include the rising incidence of cancer, expanding treatment options, and improved diagnoses. The industry is primarily dominated by players such as EVA, AstraZeneca, Merck, Eli Lilly, Pharco, Johnson & Johnson, Amgen, and Novartis among others.
Egypt Congestive Heart Failure Therapeutics Market Analysis
The Egypt Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $29 Mn in 2022 to $51 Mn by 2030, with a CAGR of 7.3% during the forecast period of 2022-2030. The primary drivers in Egypt are the increasing incidence of cardiovascular illnesses, increased consciousness, early detection made possible by technological developments in the field, and the revolutionary stage of CHF treatments with ongoing research and development. The Egypt Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Roche, Gilead Sciences, Copad Pharma, EVA Pharma, Pharco, Pharmaceuticals, Tabia Pharmaceuticals, etc, among various others.
Egypt Biosensors Market Analysis
The Egypt Biosensors Market was valued at $80.9 Mn in 2023 and is predicted to grow at a CAGR of 9.5% from 2023 to 2030, to $152.7 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, aging population, and growing demand for Point-of-Care (POC) testing. The prominent players of the Egypt Biosensors Market are BM-Egypt, Kimal, Medtronic, Abbot Laboratories, and Johnson & Johnson, among others
Egypt Digital Biomarkers Market Analysis
Egypt Digital Biomarkers Market was valued at $8.12 Mn in 2023 and is predicted to grow at a CAGR of 23.8% from 2023 to 2030, to $36.19 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, government initiatives, and a growing focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Egypt Medication Access Programs Market Analysis
The Egypt Medication Access Programs Market was valued at $15.4 Mn in 2023 and is predicted to grow at a CAGR of 16.1% from 2023 to 2030, to $43.7 Mn by 2030. The key drivers of this industry include disease burden, government initiatives, and patient education and awareness. The industry is primarily dominated by players such as Takeda Pharmaceuticals, Pfizer, Novartis, and Merck among others.
Egypt Cardiac Resynchronization Therapy Market
Egypt Cardiac Resynchronization Therapy Market valued at $13 Mn in 2022, projected to reach $22 Mn by 2030 with a 6.5% CAGR. The significant rise in global heart failure instances, driven by aging populations and cardiovascular conditions linked to lifestyle, emerges as a crucial catalyst propelling the expansion of the Cardiac Resynchronization Therapy (CRT) market. Currently, major participants in this market include Abbott, Biotronik, Boston Scientific, Medtronic, St. Jude Medical, Sorin Group, Siemens Healthineers, Philips Healthcare, GE Healthcare, and Esaote.
Egypt Physiotherapy Equipment Market Analysis
The Egypt Physiotherapy Equipment Market was valued at $58.52 Mn in 2023 and is predicted to grow at a CAGR of 8.7% from 2023 to 2030, to $104.93 Mn by 2030. The key drivers of this industry include the rising prevalence of chronic diseases, expanding geriatric population, and advancements in technology. The key players in the industry are AB Care Medical Technology, BTL Industries, AMECO Egypt, and Blue Shell Store among others.
Egypt Patient Adherence Programs Market Analysis
The Egypt Patient Adherence Programs Market was valued at $36.3 Mn in 2023 and is predicted to grow at a CAGR of 19.5% from 2023 to 2030, to $126.2 Mn by 2030. The key drivers of the market include increasing non-adherence, rising chronic conditions, and an aging population. The prominent players in the Egypt Patient Adherence Programs Market are Eva Pharma, Rameda Pharmaceuticals, MUP (Medical Union Pharmaceuticals), Sedico Pharmaceuticals, and EIPICO (Egyptian International Pharmaceutical Industries Co), among others.
Egypt Cardiac Arrhythmia Therapeutics Market
Egypt Cardiac Arrhythmia Therapeutics Market valued at $20 Mn in 2022, projected to reach $35 Mn by 2030 with a 7.3% CAGR. The key drivers of this industry include the increasing prevalence of cardiac arrhythmias, government initiatives, and technological advances. The industry is primarily dominated by players such as Abbott, Hikma, EPharm, Pharco, Sanofi, Boehringer Ingelheim, and AstraZeneca among others.
Egypt LASIK Surgery Market Analysis
Egypt LASIK Surgery Market was valued at $9.88 Mn in 2023 and is predicted to grow at a CAGR of 6.71% from 2023 to 2030, to $15.57 Mn by 2030. The key drivers of this industry include the rising prevalence of vision problems, growing middle class and disposable income, and increasing awareness and marketing. The industry is primarily dominated by Johnson & Johnson Vision, Zeimer Ophthalmic System AG, Abbott, and Carl ZEISS AG, among others.
Egypt Medical Digital Imaging System Market Analysis
The Egypt Medical Digital Imaging System Market was valued at $85.4 Mn in 2023 and is predicted to grow at a CAGR of 9.7% from 2023 to 2030, to $163.27 Mn by 2030. The key drivers of this industry include a rising aging population, increasing healthcare investment, and supportive government initiatives. The industry is primarily dominated by players such as Siemens Healthineers, GE Healthcare, Philips Healthcare, and Canon Medical Systems among others.
Egypt Breastfeeding Accessories Market Analysis
Egypt Breastfeeding Accessories Market was valued at $7.03 Mn in 2023 and is predicted to grow at a CAGR of 8.30% from 2023 to 2030, to $12.28 Mn by 2030. The key drivers of this industry include increasing awareness of breastfeeding benefits, a rising middle-class population, and improved healthcare infrastructure. The industry is primarily dominated by Medala, Elvie, Willow Innovations, and Koninklijke Philips among others.